United States Medical Compression Alliance

Medical compression manufacturers industry alliance.

Based in GA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $40K in lobbying spend across 5 quarterly filings, United States Medical Compression Alliance is an active lobbying client. Their lobbying covers 1 issue area. Active from 2023 to 2024.

$40K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$40K
2024$0

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

Mcdermott+ LLC

Lobbyists

Leigh FeldmanChristopher SalmenRodney Whitlock

Government Agencies Targeted

These are the government entities that United States Medical Compression Alliance disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEOffice of Management & Budget (OMB)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

Regulatory implementation of the Lymphedema Treatment Act.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

American College of Rheumatology
$3.2M total spend
Gentiva (Formerly Reported as Humana & Kindred at Home)
$1.8M total spend
Augusta University Research Institute
$1.6M total spend
Avanos Medical, INC. (FKA Halyard Health, INC.)
$1.5M total spend
Primerica, INC.
$1.1M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.